expand_moreexpand_lessexpand_moreexpand_less
|
 |
Seema SinghNews18 |
The Technology Development Board ran through its budget in weeks. Approved VCs are next. The harder ask, persuading one more stakeholder to respond to...
Organon’s Q1 numbers on 30 April showed how Sun bought its worst quarter. But India’s biggest pharma company will hope it doesn’t get worse...
By making high-value chemicals from biomass, at mouth-watering gross margins, and replacing petroleum-derived products
The six largest ones control a fifth of the NSE500 profit pool, and the skew will only get worse
The most aggressive acquisition strategy in Indian healthcare has bruised Manipal’s margins, but some essential metrics could surprise the critics
login
who are we?
contact us
qosheapp
